noscript

News and Announcements

Australian Patent Granted for Use of Midkine for Hair Growth

  • Published January 13, 2015 1:49PM UTC
  • Publisher Wholesale Investor
  • Categories Company Updates

Source: ASX; Published: Sydney, 12th January 2015

Cellmid Limited (ASX:CDY) has received official Notice of Acceptance from IP Australia for Cellmid’s patent application 2011220326.

This patent protects the use of midkine and the closely related protein pleiotrophin for use as a hair loss and/or hair growth treatments. The granted claims cover topical formulations of all kinds, including shampoos, conditioners,creams and lotions with protection until 2031.

This patent family adds to the already considerable intellectual property assets of Cellmid’s wholly owned anti-aging hair growth subsidiary, Advagen, which include patent protection and extensive know-how around its FGF5 inhabiting technologies, cell based assays, formulations and brands.

To read the full announcement please download the document below.

Capital Insights
The Index Approach in Early-Stage Venture Capital: Reconsidered

The venture capital (VC) landscape is marked by its dynamism and complexity, especially in early-stage investing. The traditional approach in VC, characterised by a selective and intensive vetting process, often contrasts with the concept of ‘index investing.’ This article revisits the indexing approach in early-stage VC, incorporating insights from recent studies and data, including a […]

Capital Insights
The Future Is Now: The Evolution of Dealflow with Wholesale Investor

If you’ve ever thought of investing or expanding your portfolio, there’s no better time than the present. In the fast-paced world of investment, things are changing at a breathtaking speed, and it’s crucial to stay ahead of the game. The Future of Deal Flow is Today Dealflow, the lifeblood of the investment world, is not […]

Join over 45,000+ sophisticated investors

Join Now